Clinical trial
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
NCT07816185
Study timeline
Study start (actual)2026-08-31Date precision: day
Registry last updated2026-09-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Hypertensionunresolved
Interstitial Lung Diseaseunresolved
Vascular Diseasesunresolved
Cardiovascular Diseasesunresolved
Fibrosisunresolved
Interventions
Sponsors & collaborators
Pulmovant, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07816185 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.